Agency Information Collection Activities; Proposals, Submissions, and Approvals:
Federal Register Volume 76, Number 145 (Thursday, July 28, 2011)
Notices
Pages 45259-45261
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
FR Doc No: 2011-19139
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. FDA-2011-N-0510
Agency Information Collection Activities; Proposed Collection;
Comment Request; Substances Prohibited From Use in Animal Food or Feed
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the recordkeeping requirements for substances prohibited for use in animal food or feed.
DATES: Submit electronic or written comments on the collection of information by September 26, 2011.
ADDRESSES: Submit electronic comments on the collection of information to: http://www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA- 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of
Page 45260
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-7651,
Juanmanuel.vilela@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document.
With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.
Substances Prohibited From Use in Animal Food or Feed--21 CFR Part 589
(OMB Control Number 0910-0627)--(Extension)
The final rule on bovine spongiform encephalopathy (BSE) (73 FR 22720, April 25, 2008) prohibits the use of certain cattle origin materials in the food or feed of all animals to help prevent the spread of BSE in U.S. cattle. BSE is a progressive and fatal neurological disorder of cattle that results from an unconventional transmissible agent. BSE belongs to the family of diseases known as transmissible spongiform encephalopathies (TSEs). All TSEs affect the central nervous system of infected animals. These measures will further strengthen existing safeguards against BSE.
Description of Recordkeeping for Respondents: Rendering facilities, medicated feed manufacturers, livestock feeders.
FDA estimates the burden of this collection of information as follows:
Table 1--Estimated Annual Recordkeeping Burden \1\
Total
Number of
Number of
Total annual Average burden
operating and 21 CFR Section
recordkeepers records per
records
per
Total hours
maintenance recordkeeper
recordkeeper
costs
589.2001 (c)(2)(vi) and (c)(3)(i).......................
175
1
175
20
3,500
$59,500 589.2001 (c)(2)(ii).....................................
50
1
50
20
1,000
17,000 589.2001 (c)(3)(i)(A)...................................
175
1
175
26
4,550
80,580
Total............................................... .............. .............. .............. ..............
9,050
157,080
\1\ There are no capital costs associated with this collection of information.
The number of recordkeepers times the number of records per recordkeeper equals total annual records. Total annual records times average burden per recordkeeper equals total hours.
Description of Respondents for Reporting; The final rule on BSE (73
FR 22720) included a provision that exempts cattle materials prohibited in animal feed (CMPAF) from designated countries from the prohibition on its use in animal feed (21 CFR 589.2001(b)(1)(vi)). A foreign country seeking this designation will submit a written request to FDA that includes a variety of information about the countries' BSE status
(21 CFR 589.2001(f)). FDA estimates that 10 countries could submit a request to FDA to be exempted from CMPAF restrictions.
FDA estimates the reporting burden for this information collection as follows:
Table 2--Estimated One-Time and Recurring Reporting Burden \1\
Number of 21 CFR Section
Number of
responses per Total annual Average burden
Total hours respondents
respondent
responses
per response
589.2001(b)(1) \2\..............
10
1
10
80
800 589.2001(f).....................
10
1
10
26
260
\1\ There are no capital costs or operating costs associated with the collection of information.
\2\ One-time burden.
Page 45261
Dated: July 20, 2011.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
FR Doc. 2011-19139 Filed 7-27-11; 8:45 am
BILLING CODE 4160-01-P
